We are live on
!
Find out more
VBIV
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
VBIV
Delisted
VBIV was delisted on the 7th of August, 2024.
70 hedge funds and large institutions have $58.8M invested in VBI Vaccines, Inc. New Common Stock (Canada) in 2019 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 23 increasing their positions, 9 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
200% more first-time investments, than exits
New positions opened: 21 | Existing positions closed: 7
156% more repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 9
25% more funds holding
Funds holding: 56 → 70 (+14)
19% more capital invested
Capital invested by funds: $49.4M → $58.8M (+$9.45M)
Holders
70
Holders Change
+14
Holders Change %
+25%
% of All Funds
1.54%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
21
Increased
23
Reduced
9
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
PA
Perceptive Advisors
New York
|
+$14M |
| 2 |
6CM
683 Capital Management
New York
|
+$1.4M |
| 3 |
Alyeska Investment Group
Chicago,
Illinois
|
+$1.11M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$934K |
| 5 |
SM
Sabby Management
Miami Beach,
Florida
|
+$612K |
Top Sellers
| 1 |
FI
Fosun International
Hong Kong,
China
|
-$1.16M |
| 2 |
MIH
Meitav Investment House
Bene-Beraq,
Israel
|
-$776K |
| 3 |
Goldman Sachs
New York
|
-$643K |
| 4 |
Blackstone Inc
New York
|
-$576K |
| 5 |
Jane Street
New York
|
-$81K |
